Welcome!

AJAX & REA Authors: Jnan Dash, Piram Manickam, Subrahmanya SV, S Sangeetha, Bob Gourley

News Feed Item

AtheroNova to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference

IRVINE, Calif., Jan. 17, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that its CEO, Thomas W. Gardner, will present at "NINE"; Noble Financial Capital Markets' Ninth Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Wednesday, January 23rd at 11:00 am Eastern Time.

Mr. Gardner will discuss milestones for 2013 for AHRO-001, the Company's lead compound for the regression of atherosclerotic plaque, as well as the Company's pipeline and clinical plans. 

In addition to the presentation, Mr. Gardner will be available to meet with analysts, industry executives and investors in one-on-one meetings.  Those interested in meeting with Mr. Gardner for a one-on-one discussion during the Conference are encouraged to contact the Company directly at info@atheronova.com.

At the time of the presentation, a live audio and high-definition video webcast of AtheroNova's presentation and a copy of the presentation materials will be available on the Noble Financial websites: www.noblefcm.com, or www.nobleresearch.com/nine/home.htm.  AtheroNova recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on www.AtheroNova.com for 90 days following the event.

About AtheroNova

AtheroNova Inc., through its wholly-owned subsidiary, AtheroNova Operations, Inc., is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits and to safely improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120 - 150  presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of AtheroNova's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; AtheroNova's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of AtheroNova's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

AtheroNova undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in AtheroNova's 2011 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).

 

SOURCE AtheroNova Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cloud Expo Breaking News
Enterprises can't close their doors just because integration tools won't cope with the volume of information that their systems produce. As each day goes by, their information will become larger and more complicated, and enterprises must constantly struggle to manage the integration of dozens (or hundreds) of systems. Apache Hadoop has quickly become the technology of choice for enterprises that need to perform complex analysis of petabytes of data, but few are aware of its potential to hand...
In an ideal developer/systems administrator’s world, most applications would deploy seamlessly to multiple platforms and scale elastically with minimal effort bringing the unprecedented agility of the cloud within immediate reach of developer teams and IT organizations. OpenStack, a RackSpace and NASA initiative, is now managed by an independent foundation and is supported by multiple vendors. It defines APIs for compute, storage, networking, services, monitoring, and additional infrastructure...
Companies around the world are moving into on-premise private cloud environments. Many connect their private cloud to their public cloud service providers. In his session at 12th Cloud Expo | Cloud Expo New York [June 10-13], Brian Patrick Donaghy will talk about examples of what worked, what failed and why we should think about this evolution.
Enterprise cloud adoption revolves around pushing the BYOD movement and focusing on data security. In his session at the 12th International Cloud Expo, Ross Brouse, COO and President of Solar VPS, will cover how cloud adoption is driven by consumerism, humanity’s need to socialize, our addiction to new gadgets and the ability of data to stay secure in a growing collaborative world. The cloud is a drug and we’re just getting hooked. Ross Brouse is the COO and President of Solar VPS. He is a tr...
Organizations across the world are increasingly starting to see the benefits of moving more and more services to the cloud. The focus on the cost-saving potential of cloud is rapidly shifting to completely transforming the business with cloud. As organizations are investing enormous sums on technology they are starting to realize that in order to maximize the return on investment and accelerate the business transformation process the first area of focus should be people. By ensuring the organiza...
A recent study by analyst firm IDC reports that in 2012, 1.7 million cloud computing-related roles across the globe could not be filled due to the lack of training, certification and experience in the applicant pool. As the global demand for cloud and big data expertise increases, employers are finding it difficult to recruit talent, which is slowing down the ability for organizations to adopt, implement, and realize benefits from innovative platforms like OpenStack. In this session join Clo...
Our more interconnected planet is accelerating the adoption and convergence of next-generation architectures, in the form of cloud, mobile and instrumented physical assets. Organizations that can effectively balance optimization and innovation, will be in a position to leverage new systems of engagement, out maneuver their peers and achieve desired outcomes. In the Opening Keynote at 12th Cloud Expo | Cloud Expo New York, IBM GM & Next Generation Platform CTO Dr Danny Sabbah will detail the crit...
The cloud-enabled data center sits at the center of IT transformation. It facilitates the interconnection and communities that come together, propelling growth for both buyers and sellers. In his session at the 12th International Cloud Expo, Gerry Fassig, CoreSite’s Vice President of Sales, will discuss how CoreSite is bringing together best-of-breed partners through the Open Cloud Exchange resulting in public, private, and hybrid cloud interconnection and management as well as connectivity to...
Companies around the world are collecting massive amounts of data everyday that’s sitting around and not being utilized. Take for example the fact that companies collect demographic and location-based data via mobile devices all the time, but have to figure out how to monetize that data. In this session, Joyent CTO and founder Jason Hoffman will examine the state of Big Data, taking a look at what we're doing now to discussing what's on the horizon, as companies prepare and realign their busines...
Planning scalable environments isn't terribly difficult, but it does require a change of perspective. During this session we'll broaden our views to think on an Internet Scale by dissecting a video publishing application built with The SoftLayer Platform, Message Queuing, Object Storage, and Drupal. By examining a scalable modular application build that can handle unpredictable traffic, you'll be able to grow your development arsenal and pick up a few strategies to apply to your own projects.